Yale University, Sanacora's employer, has a financial relationship with Janssen Pharmaceuticals
and may in the future receive financial benefits from this relationship.
However, considering the relatively limited use of this new
drug in community samples so far, Sanacora acknowledged that"there is still a real
need for additional high-quality data to be collected and analyzed in an unbiased fashion to help further guide the use of this medication.".